Skip to content

The effects of Amazake, a sweet rice wine lees drink, combined with resistance exercise on cognitive and mobility functions in the elderly: a randomized, double-blind, placebo-controlled trial

The effects of Amazake, a sweet rice wine lees drink, combined with resistance exercise on cognitive and mobility functions in the elderly: a randomized, double-blind, placebo-controlled trial - The effects of Amazake on Mobility, prevention of AlZheimer's disease And Knee pain in the Elderly: The AMAZAKE Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027158
Enrollment
40
Registered
2017-04-30
Start date
2017-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the elderly

Interventions

Amazake (a sweet rice wine lees drink) and guided resistance exercise for 12 weeks. - Amazake supplementation: approximately 50 g/day, non-alcohol, freeze-dried powder made from rice wine lees. - Ex

Sponsors

School of Human Science and Environment, University of Hyogo
Lead Sponsor
Clinical Research Institute, National Hospital Organization Kyoto Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. The elderly (ages <= 65 years) 3. Doing exercise for more than 1 year, such as stretching 4. Having provided voluntary written consent for participation in this study 5.Able to receive and take experimental supplements 6. Able to follow the instructions of the research team member

Exclusion criteria

Exclusion criteria: 1. Prohibited from doing exercise by a doctor (cardiovascular disease or other) 2. Already diagnosed as dementia by a physician or prescribed drugs for treating dementia 3. Already received nursing care certification in the Long-Term Care Insurance Law 4. Having food allergy to materials or ingredients of experimental supplement 5. Judged by the investigator/project leader to be ineligible for other reason

Design outcomes

Primary

MeasureTime frame
Change in cognitive function at 12 weeks

Secondary

MeasureTime frame
Mobility function, Physical performance, Body composition measured using electrical impedance equipment, Knee-pain score, Inflammatory markers, Frailty scale, Psychological parameters, Blood examination, Bowel movement - pre and post 12 week-intervention - single measurement, respectively

Countries

Japan

Contacts

Public ContactNarumi Nagai

University of Hyogo School of Human Science and Environment

nagai@shse.u-hyogo.ac.jp+81-79-292-1515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026